17 April 2019
Osteoarthritis is the most common rheumatic disorder. The research must form the basis for new treatments that help to reduce cartilage damage and pain due to osteoarthritis. The research group of Peter Van der Kraan is also awarded the title Research Center of Excellence by ReumaNederland.
With the Research Centers of Excellence at the forefront of osteoarthritis research, ReumaNederland wants to improve the treatment of people with osteoarthritis. Osteoarthritis affects nearly 1.4 million people in the Netherlands. Treatments are currently limited to lifestyle advice, pain relief and exercise therapy and, in the worst case, a prosthesis. In the coming period, a total of seven university research groups in the Netherlands will be named Research Centers of Excellence for osteoarthritis. Reuma Nederland provides a total of 3.8 million euros for the Osteoarthritis Research Centers.
More information (only available in Dutch): link.
Peter van der Kraan, theme Inflammatory diseases received € 500,000 for research into the development of cartilage damage and pain in knee osteoarthritis.
Osteoarthritis is the most common rheumatic disorder. The research must form the basis for new treatments that help to reduce cartilage damage and pain due to osteoarthritis. The research group of Peter Van der Kraan is also awarded the title Research Center of Excellence by ReumaNederland.
With the Research Centers of Excellence at the forefront of osteoarthritis research, ReumaNederland wants to improve the treatment of people with osteoarthritis. Osteoarthritis affects nearly 1.4 million people in the Netherlands. Treatments are currently limited to lifestyle advice, pain relief and exercise therapy and, in the worst case, a prosthesis. In the coming period, a total of seven university research groups in the Netherlands will be named Research Centers of Excellence for osteoarthritis. Reuma Nederland provides a total of 3.8 million euros for the Osteoarthritis Research Centers.
More information (only available in Dutch): link.